HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis-Reference-Cited by-同舟云学术

HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis

Published:2023-11 Issue: Volume:124 Page:111002
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Lu Hongjian^ORCID,Zhang Ronghua,Zhang Shukun,Li Yufeng,Liu Yankun,Xiong Yanan,Yu Xiaohan,Lan Tao,Li Xin,Wang Meimei,Liu Zhiyong,Zhang Guangling^ORCID,Li Jingwu^ORCID,Chen Shuang^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference42 articles.

1. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future;Friedman;Hepatology,2022

2. Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy;Kong;Redox Biol.,2020

3. Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives;Nan;Evid. Based Complement. Alternat. Med.,2022

4. The biology, function, and biomedical applications of exosomes;Kalluri;Science,2020

5. M2 Macrophage-Derived Exosomal microRNA-411-5p Impedes the Activation of Hepatic Stellate Cells by Targeting CAMSAP1 in NASH Model;Wan;iScience,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental study on H2O2 activation of HSC-T6 and hepatic fibrosis in cholestatic mice by "Yajieshaba";Journal of Ethnopharmacology;2024-12

2. Stem Cell Therapy as a Potential Treatment of Non-Alcoholic Steatohepatitis-Related End-Stage Liver Disease: A Narrative Review;Current Stem Cell Reports;2024-07-02